We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.36B
AUM Growth
-$421M
Cap. Flow
-$494M
Cap. Flow %
-36.22%
Top 10 Hldgs %
24.41%
Holding
4,677
New
965
Increased
1,296
Reduced
1,507
Closed
833

Sector Composition

Rank Sector Weight
1 Industrials 7.55%
2 Technology 7.19%
3 Financials 6.96%
4 Healthcare 6.81%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
826
Baidu
BIDU
$37.2B
$263K 0.02%
1,152
-394
-25% -$92.6K
ALB icon
827
Albemarle
ALB
$15.5B
$262K 0.02%
2,630
-2,466
-48% -$239K
FXD icon
828
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
$262K 0.02%
6,019
+3,011
+100% +$130K
TS icon
829
Tenaris
TS
$26.8B
$262K 0.02%
7,809
+7,484
+2,303% +$260K
ADT icon
830
ADT
ADT
$5.58B
$261K 0.02%
27,773
+8,355
+43% +$74.5K
BH icon
831
Biglari Holdings Class B
BH
$1.21B
$261K 0.02%
1,444
+917
+174% +$176K
DBI icon
832
Designer Brands
DBI
$333M
$261K 0.02%
7,695
+7,694
+769,400% +$225K
EWT icon
833
iShares MSCI Taiwan ETF
EWT
$10.7B
$261K 0.02%
+6,931
New +$257K
RRC icon
834
Range Resources
RRC
$8.95B
$260K 0.02%
15,282
+10,024
+191% +$161K
EWC icon
835
iShares MSCI Canada ETF
EWC
$6.33B
$259K 0.02%
9,016
+1,618
+22% +$46.7K
BSX icon
836
Boston Scientific
BSX
$71.5B
$258K 0.02%
6,695
-43,338
-87% -$1.51M
FHB icon
837
First Hawaiian
FHB
$3.35B
$258K 0.02%
+9,494
New +$272K
PCG icon
838
PG&E
PCG
$38.5B
$257K 0.02%
5,578
-13,409
-71% -$597K
MDRX
839
DELISTED
Veradigm Inc. Common Stock
MDRX
$255K 0.02%
17,861
+15,238
+581% +$207K
OGS icon
840
ONE Gas
OGS
$5.04B
$254K 0.02%
3,088
+2,303
+293% +$180K
CURO
841
DELISTED
CURO Group Holdings Corp.
CURO
$254K 0.02%
+8,398
New +$241K
PPH icon
842
VanEck Pharmaceutical ETF
PPH
$938M
$253K 0.02%
3,934
-23,306
-86% -$1.45M
ALLY icon
843
Ally Financial
ALLY
$13.3B
$252K 0.02%
9,530
+3,826
+67% +$104K
AZN icon
844
AstraZeneca
AZN
$250B
$251K 0.02%
3,178
+2,966
+1,399% +$224K
D icon
845
Dominion Energy
D
$59.3B
$251K 0.02%
3,574
-17,376
-83% -$1.23M
RPAI
846
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$251K 0.02%
20,620
-2,345
-10% -$29.5K
TLYS icon
847
Tilly's
TLYS
$128M
$250K 0.02%
+13,197
New +$227K
BKH icon
848
Black Hills Corp
BKH
$5.68B
$249K 0.02%
4,287
+465
+12% +$27.9K
MDP
849
DELISTED
Meredith Corporation
MDP
$249K 0.02%
4,892
+3,168
+184% +$166K
CISN
850
DELISTED
Cision Ltd. Ordinary Share
CISN
$249K 0.02%
+14,837
New +$244K

Similar funds

Tower Research Capital (TRC)'s Q3 2018 Portfolio in Review

As of Q3 2018, Tower Research Capital (TRC) held 4,677 positions worth $1.36B, down 24% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) withdrew a net $494M in Q3 2018, closing 833 positions and reducing 1,507 holdings. Its most notable exit was NVIDIA, an estimated $6.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 7.6% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.3M.

  • Tower Research Capital (TRC)'s largest Q3 2018 buy was Vanguard S&P 500 ETF: 53,562 shares worth $14.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $151M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2018 reduction was Apple, cutting an estimated $48.1M.
  • Tower Research Capital (TRC) fully exited NVIDIA in Q3 2018, selling an estimated $6.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.36B portfolio in Q3 2018.
  • Tower Research Capital (TRC) opened 965 new positions and closed 833 in Q3 2018.
  • Tower Research Capital (TRC)'s portfolio value fell 24% quarter-over-quarter to $1.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.